Felicitas Hitz

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group

Peter Borchmann, Helen Goergen, Carsten Kobe et al. · The Lancet · 2017 · 372 citations

Positron Emission Tomography, Advanced-stage Hodgkin, Lymphoid Neoplasia +9

Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)

Christoph Mamot, Dirk Klingbiel, Felicitas Hitz et al. · Journal of Clinical Oncology · 2015 · 183 citations

Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial

Karolin Behringer, Helen Goergen, Felicitas Hitz et al. · The Lancet · 2014 · 178 citations

Hematological Malignancy, Lymphoid Neoplasia, Ghsg Hd13 +10

Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project

Christopher P. Fox, Monica Civallero, Young-Hyeh Ko et al. · The Lancet Haematology · 2020 · 133 citations · Full text

Lymphoid Neoplasia, Survival Outcomes, Medicine +7

Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial

Ruud H. Knols, Eling D. de Bruin, Daniel Uebelhart et al. · Bone Marrow Transplantation · 2010 · 131 citations

Randomized Clinical Trial, Physical Activity, Health Policy +12